Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

NCT02632448

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +55 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
View all 16 locations
View Trial Details
Completed

Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis

NCT00922974

Conditions
Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +6 more
Locations
  • University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
  • George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus New Britain, Connecticut, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
View all 38 locations
View Trial Details
Completed

SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)

NCT04291079

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, +27 more
Locations
  • St. Jude Crosson Cancer Institute Fullerton, California, United States
  • University of California - San Diego La Jolla, California, United States
  • The Oncology Institute Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 22 locations
View Trial Details
Completed

Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma

NCT04602078

Conditions
Carcinoma, Carcinoma, Transitional Cell, Locally Advanced or Metastatic Urothelial Carcinoma, +7 more
Locations
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • ICO Hospitalet- Hospital Duran i Reynals Barcelona, Spain
  • Hospital Provincial de Castellón Castellon, Spain
  • Hospital Universitario de Jaén Jaén, Spain
View Trial Details
Completed

A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors

NCT03954067

Conditions
Advanced Cancer, DNA Virus Infections, Infections, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arizona - Arizona Cancer Center Tucson, Arizona, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
View all 17 locations
View Trial Details
Completed

Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer

NCT05673811

Conditions
Metastatic, Neoplasm Metastasis, Neoplasms, +4 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of California - Davis Cancer Center Sacramento, California, United States
  • University of Louisville - Brown Cancer Center Louisville, Kentucky, United States
  • Weill Cornell Medical Center New York, United States
View all 17 locations
View Trial Details
Completed

A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer

NCT02795988

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations
  • ARENSIA Exploratory Medicine LLC Tbilisi, Georgia
  • City Cancer Center Vijayawada, Andhra Pradesh, India
  • North East Cancer Hospital and Research Institute Guwahati, Assam, India
  • Shetty's Hospital Bengaluru, Karnataka, India
View all 22 locations
View Trial Details
Completed

Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery

NCT00576654

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Yale University New Haven, Connecticut, United States
  • University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

Genomic Testing and Resulting Medical Decisions

NCT03301493

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +70 more
Locations
  • IIIrd Medical Department, Private Medical University Hospital Salzburg Salzburg, State of Salzburg, Austria
  • Innere Medizin II, LKH Feldkirch Feldkirch, Austria
  • Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria
  • Medizinische Universität Innsbruck Innsbruck, Austria
View Trial Details

Related conditions